Zika Vaccines And Immunogenic Compositions, And Methods Of Using The Same

The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g, a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.

Saved in:
Bibliographic Details
Main Authors MARKS, Jackie, DE MOERLOOZE, Laurence, DUBIN, Gary, PATEL, Hetal, RAO, Raman, HAN, Htay Htay, KOMMAREDDY, Sushma, LIVENGOOD, Jill, DEAN, Hansi
Format Patent
LanguageEnglish
Published 05.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g, a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of treatments and uses thereof.
Bibliography:Application Number: AU20220203422